Can you sum up what your company does in six? Not six minutes. Six words. That was a challenge set to attendees at One Nucleus’s Boston Bootcamp in the US in April. It was discussed at One Nucleus’s On Helix event in Cambridge a couple of weeks ago, and it really grabbed me. It grabbed […]
SOMETHING momentous happened in the world of media earlier this month.Social media and video platforms overtook “traditional” news organisations as the most popular source of news. The results are from a highly-respected global annual survey about how news is sourced and consumed, by the Reuters Institute and Oxford University. I actually first heard about this […]
Hansa Biopharma’s ConfIdeS Phase 3 abstract selected for ‘What’s Hot, What’s New’ plenary at ATC 2026 Hansa Biopharma AB, announced on Thursday that the ConfIdeS Phase 3 abstract titled “Superior 1-year eGFR Among Highly Sensitized Patients Desensitized with Imlifidase Compared to Control” had been selected to be highlighted at the closing plenary session “What’s Hot, What’s New” at the American Transplant Congress (ATC) 2026, which took place in Boston on June […]
Hansa Biopharma appointed Adam Cutler as new Chief Financial Officer Hansa Biopharma AB announced the appointment of Adam Cutler as its new Chief Financial Officer (CFO) and member of the Executive Committee, effective June 22, 2026. Adam succeeds Evan Ballantyne, who has served as CFO since 2024. Evan will continue in the role until June […]
It’s now almost nine years since the first CAR-T therapies, Kymriah and Yescarta, were approved by the FDA. These therapies and others have revolutionised the treatment of certain hard-to-treat blood cancers, such as ALL and some B-cell lymphomas. There was rightly huge elation at the time. CAR-Ts were a real breakthrough, offering a lifeline – […]
